Collegium Pharmaceutical, Inc. Amortization of Debt Issuance Costs and Discounts
Collegium Pharmaceutical, Inc. (COLL) reported Amortization of Debt Issuance Costs and Discounts of $1.90 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2026-08-06
- Collegium Pharmaceutical, Inc. amortization of debt issuance costs and discounts for the quarter ending 2026-06-30 was $1.08M, a 20.15% decline year-over-year.
- Collegium Pharmaceutical, Inc. amortization of debt issuance costs and discounts for the quarter ending 2026-03-31 was $819.00K, a 40.09% decline year-over-year.
- Collegium Pharmaceutical, Inc. amortization of debt issuance costs and discounts for the quarter ending 2025-12-31 was $1.28M, a 10.39% decline year-over-year.
- Collegium Pharmaceutical, Inc. amortization of debt issuance costs and discounts for the quarter ending 2025-09-30 was $1.34M, a 11.18% increase year-over-year.
- Collegium Pharmaceutical, Inc. amortization of debt issuance costs and discounts for fiscal 2025 was $5.34M, a 11.22% decline from fiscal 2024.
- Collegium Pharmaceutical, Inc. amortization of debt issuance costs and discounts for fiscal 2024 was $6.02M, a 30.33% decline from fiscal 2023.
- Collegium Pharmaceutical, Inc. amortization of debt issuance costs and discounts for fiscal 2023 was $8.63M, a 4.22% increase from fiscal 2022.
- Collegium Pharmaceutical, Inc. amortization of debt issuance costs and discounts for fiscal 2022 was $8.29M, a 143.25% increase from fiscal 2021.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.90M 10-Q · filed 2026-08-06 | $3.18M derived: sum of 3 quarters · filed 2026-08-06 | $4.52M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $819.00K 10-Q · filed 2026-05-07 | $2.10M derived: sum of 2 quarters · filed 2026-05-07 | $3.44M derived: sum of 3 quarters · filed 2026-05-07 | $4.79M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.62M derived: sum of 2 quarters · filed 2026-02-26 | $3.97M derived: sum of 3 quarters · filed 2026-08-06 | $5.34M 10-K · filed 2026-02-26 |
| 2025-09-30 | $1.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.70M derived: sum of 2 quarters · filed 2026-08-06 | $4.07M 10-Q · filed 2025-11-06 | $5.49M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.72M 10-Q · filed 2026-08-06 | $4.15M derived: sum of 3 quarters · filed 2026-08-06 | $5.35M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.37M 10-Q · filed 2026-05-07 | $2.79M derived: sum of 2 quarters · filed 2026-05-07 | $4.00M derived: sum of 3 quarters · filed 2026-05-07 | $5.60M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.63M derived: sum of 2 quarters · filed 2026-02-26 | $4.24M derived: sum of 3 quarters · filed 2026-02-26 | $6.02M 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.81M derived: sum of 2 quarters · filed 2025-11-06 | $4.59M 10-Q · filed 2025-11-06 | $6.55M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $3.38M 10-Q · filed 2025-08-07 | $5.35M derived: sum of 3 quarters · filed 2026-02-26 | $7.47M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $1.78M 10-Q · filed 2025-05-08 | $3.74M derived: sum of 2 quarters · filed 2026-02-26 | $5.87M derived: sum of 3 quarters · filed 2026-02-26 | $8.13M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.09M derived: sum of 2 quarters · filed 2026-02-26 | $6.35M derived: sum of 3 quarters · filed 2026-02-26 | $8.63M 10-K · filed 2026-02-26 |
| 2023-09-30 | $2.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $4.38M derived: sum of 2 quarters · filed 2024-11-07 | $6.67M 10-Q · filed 2024-11-07 | $9.05M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $2.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $4.55M 10-Q · filed 2024-08-08 | $6.93M derived: sum of 3 quarters · filed 2025-02-27 | $9.40M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $2.29M 10-Q · filed 2024-05-09 | $4.67M derived: sum of 2 quarters · filed 2025-02-27 | $7.14M derived: sum of 3 quarters · filed 2025-02-27 | $9.66M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $4.85M derived: sum of 2 quarters · filed 2025-02-27 | $7.37M derived: sum of 3 quarters · filed 2025-02-27 | $8.29M 10-K · filed 2025-02-27 |
| 2022-09-30 | $2.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $4.99M derived: sum of 2 quarters · filed 2023-11-07 | $5.90M 10-Q · filed 2023-11-07 | $6.68M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $2.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $3.44M 10-Q · filed 2023-08-03 | $4.21M derived: sum of 3 quarters · filed 2024-02-22 | $5.05M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $913.00K 10-Q · filed 2023-05-04 | $1.69M derived: sum of 2 quarters · filed 2024-02-22 | $2.52M derived: sum of 3 quarters · filed 2024-02-22 | $3.40M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $779.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $1.61M derived: sum of 2 quarters · filed 2024-02-22 | $2.49M derived: sum of 3 quarters · filed 2024-02-22 | $3.41M 10-K · filed 2024-02-22 |
| 2021-09-30 | $832.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $1.71M derived: sum of 2 quarters · filed 2022-11-03 | $2.63M 10-Q · filed 2022-11-03 | $5.17M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $876.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.79M 10-Q · filed 2022-08-04 | $4.34M derived: sum of 3 quarters · filed 2023-02-23 | $6.91M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $919.00K 10-Q · filed 2022-05-10 | $3.46M derived: sum of 2 quarters · filed 2023-02-23 | $6.03M derived: sum of 3 quarters · filed 2023-02-23 | $8.55M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $5.11M derived: sum of 2 quarters · filed 2023-02-23 | $7.64M derived: sum of 3 quarters · filed 2023-02-23 | $8.97M 10-K · filed 2023-02-23 |
| 2020-09-30 | $2.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $5.09M derived: sum of 2 quarters · filed 2021-11-04 | $6.43M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $2.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $3.86M 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $1.34M 10-Q · filed 2021-05-06 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | -$1.00K derived: sum of 2 quarters · filed 2017-03-10 | $6.00K 10-K · filed 2017-03-10 | |
| 2015-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $6.00K 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | $7.00K 10-Q · filed 2016-08-11 | |||
| 2014-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $3.00K derived: sum of 2 quarters · filed 2017-03-10 | $6.00K derived: sum of 3 quarters · filed 2017-03-10 | $7.00K 10-K · filed 2017-03-10 |
| 2014-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $5.00K derived: sum of 2 quarters · filed 2015-11-12 | $6.00K 10-Q · filed 2015-11-12 | |
| 2014-06-30 | $3.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2015-08-12 | $4.00K 10-Q · filed 2015-08-12 | ||
| 2014-03-31 | $1.00K 10-Q/A · filed 2015-07-17 | |||
| 2013-12-31 | $12.00K 10-K · filed 2016-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |